NVCR

NVCR R&D Expenses

$224.72MTTM · USD

Period ending:

NVCR FY R&D ExpensesUSD
NVCR FY R&D Expenses2013-12-31: $34.80M2014-12-31: $40.38M2015-12-31: $43.75M2016-12-31: $41.47M2017-12-31: $38.10M2018-12-31: $50.57M2019-12-31: $79.00M2020-12-31: $132.01M2021-12-31: $201.30M2022-12-31: $206.09M2023-12-31: $223.06M2024-12-31: $209.65M2025-12-31: $224.54M$224.54M$0.00
2013-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

NVCR r&d expenses history

Research and development spending. The available annual fiscal periods series contains 13 observations from Dec 31, 2013 to Dec 31, 2025.

Novocure Ltd R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
224,544,000
209,645,000
223,062,000
206,085,000
201,303,000
132,010,000
79,003,000
50,574,000
38,103,000
41,467,000
43,748,000
40,381,000
34,797,000

Compare r&d expenses

All NVCR financial metrics · NVCR stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.